Close Menu

This story has been updated to include comments made by BD executives during its earnings call.

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal fourth quarter revenues rose 39 percent year over year, driven primarily by the acquisition of C. R. Bard earlier this year.

For the three months ended Sept. 30, the company posted revenues of $4.40 billion compared to $3.17 billion in the year-ago quarter, and slightly higher than Wall Street analysts' average estimate of $4.36 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.